APA

Davey R. T., Chaitt D. G., Albert J. M., Piscitelli S. C., Kovacs J. A., Walker R. E., Falloon J., Polis M. A., Metcalf J. A., Masur H., Dewar R., Baseler M., Fyfe G., Giedlin M. A. & Lane H. C. (19990421). A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. : The Journal of infectious diseases.

Chicago

Davey R T, Chaitt D G, Albert J M, Piscitelli S C, Kovacs J A, Walker R E, Falloon J, Polis M A, Metcalf J A, Masur H, Dewar R, Baseler M, Fyfe G, Giedlin M A and Lane H C. 19990421. A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. : The Journal of infectious diseases.

Harvard

Davey R. T., Chaitt D. G., Albert J. M., Piscitelli S. C., Kovacs J. A., Walker R. E., Falloon J., Polis M. A., Metcalf J. A., Masur H., Dewar R., Baseler M., Fyfe G., Giedlin M. A. and Lane H. C. (19990421). A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. : The Journal of infectious diseases.

MLA

Davey R T, Chaitt D G, Albert J M, Piscitelli S C, Kovacs J A, Walker R E, Falloon J, Polis M A, Metcalf J A, Masur H, Dewar R, Baseler M, Fyfe G, Giedlin M A and Lane H C. A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. : The Journal of infectious diseases. 19990421.